Research advances in m⁶A methylation and sepsis

Area of Science:

• Epigenetics
• Molecular Biology
• Immunology

Background:

• Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
• N6-methyladenosine (m⁶A) is the most abundant RNA modification in eukaryotes, regulating gene expression.
• m⁶A modification is dynamically regulated by writers, erasers, and readers, influencing various biological processes.

Purpose of the Study:

• To review the mechanistic insights into the role of m⁶A in sepsis pathogenesis.
• To explore the involvement of m⁶A dysregulation in sepsis-induced multi-organ damage.
• To evaluate the therapeutic potential of targeting m⁶A in sepsis.

Main Methods:

• Literature review synthesizing current research on m⁶A and sepsis.
• Analysis of mechanisms by which m⁶A influences inflammatory responses.
• Evaluation of evidence linking m⁶A to organ-specific injury in sepsis models.

Main Results:

• m⁶A dysregulation is implicated in cardiovascular dysfunction, acute lung injury, and acute kidney injury during sepsis.
• m⁶A governs inflammatory cascades and organ injury pathways.
• Specific m⁶A regulators (writers, erasers, readers) are involved in sepsis progression.

Conclusions:

• m⁶A is a critical regulator in sepsis pathogenesis and multi-organ dysfunction.
• Targeting m⁶A pathways offers potential therapeutic strategies for sepsis.
• Further research is needed to develop translational frameworks for m⁶A-based sepsis therapies.